Inventor

PRINZ BIANKA

US58 patents

⚠️ This page may combine multiple inventors who share the name “PRINZ BIANKA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PRINZ BIANKA

DRAGONFLY THERAPEUTICS INC

Antibody variable domains targeting the NKG2D receptor

Antibody variable domains targeting the NKG2D receptor

Proteins binding HER2, NKG2D and CD16

Cancer therapy involving an anti-PD1 antibody and a multi-specific binding protein that binds NKG2D, CD16, and a tumor-associated antigen

Antibody variable domains targeting the NKG2D receptor

Multi-specific binding proteins that bind HER2, NKG2D, and CD16, and methods of use

Antibody variable domains targeting the NKG2D receptor

Multi-specific binding proteins that bind CD33, NKG2D, and CD16, and methods of use

Multi-specific binding proteins that bind BCMA, NKG2D and CD16, and methods of use

Proteins binding NKG2D, CD16 and a tumor-associated antigen

TUSK THERAPEUTICS LTD

Anti-CD25 antibody agents

Anti-CD25 antibody agents

Anti-CD25 antibody agents

Anti-CD25 antibody agents

Anti-CD25 for tumour specific cell depletion

Anti-CD25 for tumour specific cell depletion

Anti-CD25 antibody agents

Anti-CD25 for tumour specific cell depletion

MERCK SHARP & DOHME

Anti-coagulation factor XI antibodies

Anti-coagulation factor XI antibodies

Anti-coagulation factor XI antibodies

Surface display of whole antibodies in eukaryotes

Anti-coagulation factor XI antibodies

Anti-coagulation factor XI antibodies

Black Belt Therapeutics Ltd

CD38 modulating antibody agents

CD38 modulating antibody

CD38 antibody

CD38 modulating antibody agents

CD38 modulating antibody

CD38 modulating antibody

UNIV TEXAS

Human PD-L2 antibodies and methods of use therefor

Human PD-L1 antibodies and methods of use therefor

Human PD-L2 antibodies and methods of use therefor

Human PD-L1 antibodies and methods of use therefor

SURFACE ONCOLOGY INC

Antibodies that bind CD39 and uses thereof

Antibodies that bind CD39 and uses thereof

Anti-IL-27 antibodies and uses thereof

Anti-CD112R compositions and methods

MERSANA THERAPEUTICS INC

Monoclonal antibodies against HER2 epitope and methods of use thereof

Monoclonal antibodies against HER2 epitope and methods of use thereof

Monoclonal antibodies against HER2 epitope and methods of use thereof

MERCK SHARP & DOHME LLC

Anti-coagulation factor XI antibodies

Surface display of whole antibodies in eukaryotes

Anti-coagulation factor XI antibodies

PRINZ BIANKA

Surface display of whole antibodies in eukaryotes

Surface display of whole antibodies in eukaryotes

NOVARTIS AG

Antibody molecules to CD73 and uses thereof

SETHURAMAN NATARAJAN

Method for increasing N-glycosylation site occupancy on therapeutic glycoproteins produced in Pichia pastoris

SURFACE ONCOLOGY LLC

Anti-CD112R compositions and methods

SEAGEN INC

Anti-TIGIT antibodies